Balyasny Asset Management
CDTX icon

Balyasny Asset Management’s Cidara Therapeutics CDTX Stock Holding History

Balyasny Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$5.71M Buy
+117,199
New +$5.71M 0.01% 847
2018
Q2 		– Sell
-590
Closed -$47K – 1615
2018
Q1 		$47K Buy
+590
New +$47K ﹤0.01% 1673